Skip to main content
. 2020 Jun 19;35(29):e233. doi: 10.3346/jkms.2020.35.e233

Table 7. Comparison of risk of HCC development after cirrhosis diagnosis, according to cause of cirrhosis.

Variables No. of cirrhosis patients No. with HCC among cirrhosis patients HRa P value
2000–2012
HBV 6,879 2,545 1
HCV 1,027 385 0.74 (0.62–0.88) 0.001
Alcohol 4,582 784 0.34 (0.30–0.39) < 0.001
NAFLD 464 98 0.49 (0.34–0.72) < 0.001
2000–2003
HBV 2,375 750 1
HCV 260 88 1.01 (0.61–1.67) 0.963
Alcohol 1,398 194 0.56 (0.40–0.78) < 0.001
NAFLD 78 14 0.40 (0.19–0.85) 0.017
2004–2008
HBV 2,551 895 1
HCV 400 134 0.66 (0.48–0.90) 0.009
Alcohol 1,761 276 0.41 (0.33–0.51) < 0.001
NAFLD 157 39 0.56 (0.25–1.26) 0.162
2009–2012
HBV 1,953 900 1
HCV 367 163 0.78 (0.61–1.03) 0.076
Alcohol 1,423 314 0.30 (0.24–0.37) < 0.001
NAFLD 229 45 0.38 (0.21–0.69) < 0.001

HCC = hepatocellular carcinoma, HR = hazard ratio, HBV = hepatitis B virus, HCV = hepatitis C virus, NAFLD = non-alcoholic fatty liver disease.

aAdjusted by Cox proportional hazards analysis for age, sex, etiologies of cirrhosis, decompensated cirrhosis (defined as the presence of ascites, hepatic encephalopathy, gastroesophageal varices or hepatorenal syndrome), hemoglobin, platelet count, bilirubin, albumin, and alanine aminotransferase.